Parallax Volatility Advisers
VIVE

Parallax Volatility Advisers’s VIVEVE MED INC VIVE Stock Holding History

Parallax Volatility Advisers’s Portfolio VIVE Stock Details VIVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-2
Closed -$11K – 4709
2017
Q4 		$11K Buy
+2
New +$10.4K ﹤0.01% 3786

Other funds holding VIVE

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return

Parallax Volatility Advisers's VIVE Position: Q1 2018 in Review

Parallax Volatility Advisers sold out of VIVEVE MED INC (VIVE) in Q1 2018, closing a stake of 2 shares — an estimated $11K sold.

Parallax Volatility Advisers first reported a position in VIVE in Q4 2017 and held it in 1 quarter. The position peaked at $11K in Q4 2017. 50 funds tracked by Wall St. Rank hold VIVE as of Q1 2018.

  • Parallax Volatility Advisers reported no remaining VIVEVE MED INC position as of Q1 2018 after selling out during the quarter.
  • Parallax Volatility Advisers sold 2 VIVEVE MED INC shares in Q1 2018, an estimated $11K.
  • Parallax Volatility Advisers first reported a position in VIVEVE MED INC in Q4 2017 and held it in 1 quarter.
  • Parallax Volatility Advisers's VIVEVE MED INC position peaked at $11K in Q4 2017.
  • 50 funds tracked by Wall St. Rank held VIVEVE MED INC as of Q1 2018.

Based on Parallax Volatility Advisers's 13F filing for Q1 2018, filed 15 May 2018.